Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
about
Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases.Bladder Cancer Recovery Pathways: A Systematic Review.Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer.Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.Challenges facing regionalization of radical cystectomy.Putting guidelines into practice: has the era of perioperative chemotherapy arrived?Circulating Tumour DNA in Muscle-Invasive Bladder CancerIncidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experienceSystematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer PatientsA Festschrift in Honor of Edward M. Messing, MD, FACSIntravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma of the Urinary Bladder: A Retrospective Multicentre StudyBiomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder CancerUpper Tract Imaging in Patients with Initial or Terminal Hematuria Suggestive of Bleeding from the Lower Urinary Tract: How Often is the Upper Urinary Tract Responsible for the Hematuria?
P2860
Q39338341-5E10745C-D32D-47C5-B636-D59AAF8C2EF2Q45934647-8407782B-1A40-4FE5-8B2D-4E223ED54700Q47134723-EEC1C204-0F18-4504-865A-F42A1FFD99CBQ49483341-198ED819-152C-453F-BDA9-B1E352BE714EQ49763935-593F1987-B05B-4B36-84D5-67B37BF4A0F8Q54960847-D3A46734-6DC7-4B1F-8EC0-A5728D15082BQ55261714-E9A8064F-7768-47A1-A76B-5D4C4428B40BQ57166936-90770197-AC77-41A2-9CF5-AB0ED0A7B75EQ57640095-85146772-4DCF-477F-A5DE-0C1A97823285Q57825314-711DFCF1-857C-4D6C-8E51-21B64700C441Q58691149-43D34E0D-99A7-4E34-A485-50222807D86BQ58705075-ADE9BB67-F4FB-413C-B216-DC677763B013Q58736803-65893707-EA28-4288-A912-A2E79DF13562Q58775509-AF995BFE-5306-425C-8F4A-7EC10481A2FF
P2860
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
@en
type
label
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
@en
prefLabel
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
@en
P2093
P2860
P1476
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
@en
P2093
Anthony L Zietman
Ashish M Kamat
Bernard H Bochner
Diane Z Quale
Jeff M Michalski
Jeffrey M Holzbeierlein
Jonathan E Rosenberg
Joshua J Meeks
Robert Dreicer
Roger Chou
P2860
P304
P356
10.1016/J.JURO.2017.04.086
P407
P50
P577
2017-04-26T00:00:00Z